ClinicalTrials.gg
TerminatedNCT03764644ATTENTIOUpdated Dec 5, 2018

Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders

An interventional study of Combined ABMT and CBT and Combined Sham ABMT and CBT in Anxiety Disorder, Anxiety Disorder of Childhood and Separation Anxiety Disorder of Childhood, Early Onset, sponsored by Erasmus Medical Center. Terminated at 1 site in Netherlands. Open to participants aged 8 Years to 16 Years. Per ClinicalTrials.gov, last updated 2018-12-05.

Sponsored by Erasmus Medical Center · Not applicable, Interventional, and Treatment

Why this study was terminated
Interim results showed high futility to continue

From the registry’s dates

  • Registered 5 years 1 month after the study started (first participant enrolled Oct 2013, registered Nov 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Randomized
Ages
8 Years to 16 Years
Sex
All
01

Study summary

Anxiety disorders are the most common childhood psychiatric disorders, with prevalence rates as high as 15% to 20%. Success rates of the first choice treatment strategy (i.e. Cognitive Behavioural Therapy; CBT) are around 50%. Non-response increases the risk for other psychiatric disorders, school dropout, social isolation, alcoholism, and suicide attempts. These negative consequences endorse the urgent need to develop more effective and accessible treatments that enhance effectiveness of current treatment options. A promising new treatment for childhood anxiety disorders is Attention Bias Modification Treatment (ABMT). ABMT is based on evidence that anxiety-disordered individuals selectively allocate their attention toward threatening information (i.e. attention bias). This bias in early and automatic attention processes starts a cascade of subsequent biases in information processing and memory, resulting in heightened anxiety. Attention bias is an underlying mechanism of anxiety. Thus ABMT, which implicitly trains individuals to attend away from threatening information should alleviate anxiety. In contrast to ABMT, CBT explicitly targets later stages of information processing that are under volitional control. Meta-analyses of studies in adults have shown that ABMT indeed results in increased recovery rates and clinically significant changes in anxiety, compared to so-called "sham" attention training (control condition). Imaging studies have shown that ABMT modifies lateral prefrontal cortex activity to emotional stimuli. Despite its promising results, fewer studies have examined ABMT in anxiety-disordered children. The aim of this trial is to enhance treatment effectiveness by combining web-based ABMT with CBT in a large sample of anxiety-disordered children. The primary aim is to compare ABMT-augmented CBT with CBT as monotherapy on recovery rates for anxiety disorders and changes in anxiety. The secondary aim is to compare ABMT with sham attention training on anxiety disorder recovery rates and changes in anxiety. We hypothesize that (1) ABMT-augmented CBT will result in a significantly better treatment success than CBT alone, and (2) ABMT will result in a significantly better treatment success than sham attention training. The design will be a randomized, double-blind, sham-controlled clinical trial.

Read the detailed description

Anxiety disorders are the most prevalent psychiatric disorders, occurring in among 15% to 20% of children. Cognitive behavioral therapy (CBT) is currently the first-choice treatment for anxiety-disordered children. Despite proven efficacy, almost half of them do not respond, causing prolonged suffering. Children with persistent anxiety have an increased risk for other psychiatric disorders, school dropout, social isolation, alcoholism, and suicide attempts. Another concern is that only a small proportion of anxiety-disordered children actually receive treatment. These negative consequences in combination with the limited accessibility of treatment endorse the urgent need to develop more effective and accessible treatments that can enhance effectiveness of current treatment options.

A newly emerging and promising childhood anxiety treatment is Attention Bias Modification Treatment (ABMT). ABMT is build upon evidence that anxious children tend to selectively focus their attention on threatening information in the context of other non-threatening information, and that attention bias is related to development and maintenance of anxiety disorders. Children with an attention bias scan their environment for potential threat or danger thereby starting a cascade of subsequent processing biases in interpretation and memory, resulting in heightened anxiety.

Hence, as attention bias is an underlying mechanism of anxiety, treatment that diminishes attention bias toward threat in anxiety-disordered individuals should alleviate anxiety. Subsequently, several researchers began to examine the effect of ABMT, which implicitly trains anxiety-disordered individuals to attend away from threat toward neutral information. This is a different approach than CBT, which does not target early and automatic information processes, but addresses later stages of information processing that are under volitional control. Several studies highlighted the potential of ABMT in reducing anxiety levels in adults. A meta-analysis revealed that ABMT in adults produces significantly greater reductions in anxiety than sham control training, with a large effect size in clinical populations. A previous study found that 72% of the adults were free from their primary anxiety disorder after ABMT as compared to 11% after sham attention training, which is far more than CBT. These training effects were maintained at 4-month follow-up. Importantly, ABMT also modifies neural systems that are involved in the control of attention to emotional stimuli, in particular the lateral prefrontal cortex.

Despite the promising results in adults, ABMT has been scarcely examined in children. A few studies demonstrated a significant anxiolytic effect of ABMT, but not of the sham control condition. A major limitation of previous studies is that sample sizes were quite low and that a limited number of training sessions were provided. It has been shown that more training sessions enhance the magnitude of treatment effect. This is the first study that examines the effectiveness of a 9-session web-based ABMT in a large sample of anxiety-disordered children as well as examines the additive effect of web-based ABMT on CBT.

As reviewed above, childhood anxiety disorders are highly prevalent and debilitating, and there is an urgent need for improvement of current treatment strategies. An innovative, but scarcely examined, treatment option for childhood anxiety disorders is ABMT. A randomized, sham-controlled, double-blind trial of web-based Attention Bias Modification Treatment for childhood anxiety disorders will be conducted. One hundred twenty-eight children will be randomly allocated to a 9 session internet-delivered ABMT or sham attention training. The primary aim is to compare ABMT-augmented CBT with CBT as monotherapy on recovery rates for anxiety disorders and changes in anxiety. The secondary aim is to compare ABMT with sham attention training on anxiety disorder recovery rates and changes in anxiety.

02

Conditions studied

  • Anxiety Disorder
  • Anxiety Disorder of Childhood
  • Separation Anxiety Disorder of Childhood, Early Onset
  • Specific Phobia
  • Social Anxiety Disorder
  • Generalized Anxiety Disorder
03

In context

Anxiety Disorders

7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's enrollment of 55 is below the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Erasmus Medical Center is the lead sponsor of 478 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Eligible for participation are children (aged 8 to 16 years)
  • Primary diagnosis of separation anxiety disorder,
  • Primary diagnosis of generalized anxiety disorder
  • Primary diagnosis of specific phobia
  • Primary diagnosis of social phobia

Exclusion criteria

Exclusion Criteria:

  • IQ below 85
  • poor command of the Dutch language
  • serious physical disease
  • psychosis
  • substance abuse
  • pervasive developmental disorder
  • obsessive-compulsive disorder
  • posttraumatic stress disorder
  • acute stress disorder
  • panic disorder
  • major depression
  • anxiety medication during treatment
  • any concurrent psychotherapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    Combined ABMT and CBT

    9 sessions of Attention Bias Modification Treatment (dot-probe based of 160 trials) followed by individual Cognitive Behavioral Therapy via FRIENDS program

    Behavioral: Combined ABMT and CBT

  • Sham comparator
    Combined Sham ABMT and CBT

    9 sessions of Sham Attention Bias Modification Treatment (dot-probe based of 160 trials) followed by individual Cognitive Behavioral Therapy via FRIENDS program

    Behavioral: Combined Sham ABMT and CBT

Interventions

  • BehavioralCombined ABMT and CBT

    ABMT: A trial begins with a fixation cross (+) for 500 ms, immediately followed by a stimuli pair consisting of a neutral and threatening stimulus that is centred horizontally. Stimuli pairs consist of two faces, pictures or words. After presentation of the stimuli pair, a probe (: or ..) always appears on the location of the neutral stimulus. The probe remains on the screen until the participant presses the corresponding key (: or ..), after which the next trial begins. Each session, participants see 160 trials of which 128 trials include one neutral and one threatening stimulus. The remaining 32 trials include a neutral-neutral stimuli pair. CBT: FRIENDS program individual

  • BehavioralCombined Sham ABMT and CBT

    ABMT: A trial begins with a fixation cross (+) for 500 ms, immediately followed by a stimuli pair consisting of a neutral and threatening stimulus that is centred horizontally. Stimuli pairs consist of two faces, pictures or words. After presentation of the stimuli pair, a probe (: or ..) always appears on the location of the neutral stimulus. The probe remains on the screen until the participant presses the corresponding key (: or ..), after which the next trial begins. Of the 160 trials, the probe appears with equal frequency on the location of the neutral and threatening stimulus (128 trials). The remaining 32 trials include a neutral-neutral stimuli pair. CBT: FRIENDS program individual

06

What researchers measure

Primary outcomes

  1. Anxiety disorder status

    Free of any anxiety disorder according to the Anxiety Disorders Interview Schedule for Children (ADIS-C)

    Time frame: After 3 weeks of ABMT or sham-ABMT

  2. Anxiety disorder status

    Free of any anxiety disorder according to the Anxiety Disorders Interview Schedule for Children (ADIS-C)

    Time frame: After 10 weeks of CBT

  3. Anxiety disorder status

    Free of any anxiety disorder according to the Anxiety Disorders Interview Schedule for Children (ADIS-C)

    Time frame: 6 months follow-up (from last CBT session)

Secondary outcomes

  1. Number of anxiety disorders

    Number of anxiety disorders according to the Anxiety Disorders Interview Schedule for Children (ADIS-C)

    Time frame: After 3 weeks of ABMT or sham-ABMT, after 10 weeks of CBT, 6 months follow-up

  2. Anxiety symptoms

    Total scale anxiety symptoms according to the Screen for Child Anxiety Related Emotional Disorders (SCARED-R), 69 items, range 0-138, higher score represents more symptoms

    Time frame: After 3 weeks of ABMT or sham-ABMT, after 10 weeks of CBT, 6 months follow-up

  3. Depression symptoms

    Total scale depression symptoms according to the Child Depression Inventory (CDI), 27 items, range 0-54, higher score represents more symptoms

    Time frame: After 3 weeks of ABMT or sham-ABMT, after 10 weeks of CBT, 6 months follow-up

  4. Number of anxiety disorders

    Number of anxiety disorders according to the Anxiety Disorders Interview Schedule for Children (ADIS-C)

    Time frame: After 10 weeks of CBT

  5. Anxiety symptoms

    Total scale anxiety symptoms according to the Screen for Child Anxiety Related Emotional Disorders (SCARED-R), 69 items, range 0-138, higher score represents more symptoms

    Time frame: After 10 weeks of CBT

  6. Depression symptoms

    Total scale depression symptoms according to the Child Depression Inventory (CDI), 27 items, range 0-54, higher score represents more symptoms

    Time frame: After 10 weeks of CBT

  7. Number of anxiety disorders

    Number of anxiety disorders according to the Anxiety Disorders Interview Schedule for Children (ADIS-C)

    Time frame: 6 months follow-up (from last CBT session)

  8. Anxiety symptoms

    Total scale anxiety symptoms according to the Screen for Child Anxiety Related Emotional Disorders (SCARED-R), 69 items, range 0-138, higher score represents more symptoms

    Time frame: 6 months follow-up (from last CBT session)

  9. Depression symptoms

    Total scale depression symptoms according to the Child Depression Inventory (CDI), 27 items, range 0-54, higher score represents more symptoms

    Time frame: 6 months follow-up (from last CBT session)

07

Study locations

1 site
  • Erasmus MC - Sophia Children's Hospital
    Rotterdam, Zuid-Holland 3000 CB, Netherlands
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2013 to primary completion in Feb 2017, 40 months.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 30, 2018
First posted
Dec 5, 2018
StartActual
Oct 2013
Primary completionActual
Feb 2017
CompletionActual
Jul 2017
Last update
Dec 5, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 5, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03764644
Responsible party
Jeroen Legerstee (Principal Investigator, Erasmus Medical Center) — Principal investigator
First posted
Dec 5, 2018
Start date
Oct 2013
Primary completion
Feb 2017
Completion
Jul 2017
Last update
Dec 5, 2018

Study contacts

Jeroen Legerstee, PhD
principal investigator · Erasmus Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion